193 related articles for article (PubMed ID: 11313783)
21. Adenovirus E1a protein enhances the cytotoxic effects of the herpes thymidine kinase-ganciclovir system.
Parada C; Hernández Losa J; Guinea J; Sánchez-Arévalo V; Fernández Soria V; Alvarez-Vallina L; Sánchez-Prieto R; Ramón y Cajal S
Cancer Gene Ther; 2003 Feb; 10(2):152-60. PubMed ID: 12536204
[TBL] [Abstract][Full Text] [Related]
22. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system.
Smythe WR; Hwang HC; Amin KM; Eck SL; Davidson BL; Wilson JM; Kaiser LR; Albelda SM
Cancer Res; 1994 Apr; 54(8):2055-9. PubMed ID: 8174104
[TBL] [Abstract][Full Text] [Related]
23. The effect of promoter strength in adenoviral vectors containing herpes simplex virus thymidine kinase on cancer gene therapy in vitro and in vivo.
Elshami AA; Cook JW; Amin KM; Choi H; Park JY; Coonrod L; Sun J; Molnar-Kimber K; Wilson JM; Kaiser LR; Albelda SM
Cancer Gene Ther; 1997; 4(4):213-21. PubMed ID: 9253506
[TBL] [Abstract][Full Text] [Related]
24. Retrovirus-mediated transfer of the herpes simplex virus thymidine kinase and connexin26 genes in pancreatic cells results in variable efficiency on the bystander killing: implications for gene therapy.
Carrió M; Mazo A; López-Iglesias C; Estivill X; Fillat C
Int J Cancer; 2001 Oct; 94(1):81-8. PubMed ID: 11668482
[TBL] [Abstract][Full Text] [Related]
25. Connexin 43 SUMOylation improves gap junction functions between liver cancer stem cells and enhances their sensitivity to HSVtk/GCV.
Shen Y; Li Y; Ma X; Wan Q; Jiang Z; Liu Y; Zhang D; Liu X; Wu W
Int J Oncol; 2018 Mar; 52(3):872-880. PubMed ID: 29393359
[TBL] [Abstract][Full Text] [Related]
26. Recombinant AAV-mediated HSVtk gene transfer with direct intratumoral injections and Tet-On regulation for implanted human breast cancer.
Li ZB; Zeng ZJ; Chen Q; Luo SQ; Hu WX
BMC Cancer; 2006 Mar; 6():66. PubMed ID: 16539746
[TBL] [Abstract][Full Text] [Related]
27. Fusion enzymes containing HSV-1 thymidine kinase mutants and guanylate kinase enhance prodrug sensitivity in vitro and in vivo.
Ardiani A; Sanchez-Bonilla M; Black ME
Cancer Gene Ther; 2010 Feb; 17(2):86-96. PubMed ID: 19763147
[TBL] [Abstract][Full Text] [Related]
28. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
29. HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells.
Matuskova M; Hlubinova K; Pastorakova A; Hunakova L; Altanerova V; Altaner C; Kucerova L
Cancer Lett; 2010 Apr; 290(1):58-67. PubMed ID: 19765892
[TBL] [Abstract][Full Text] [Related]
30. A tandemly repeated thyroglobulin core promoter has potential to enhance efficacy for tissue-specific gene therapy for thyroid carcinomas.
Takeda T; Yamazaki M; Minemura K; Imai Y; Inaba H; Suzuki S; Miyamoto T; Ichikawa K; Kakizawa T; Mori J; DeGroot LJ; Hashizume K
Cancer Gene Ther; 2002 Oct; 9(10):864-74. PubMed ID: 12224028
[TBL] [Abstract][Full Text] [Related]
31. Bystander tumoricidal effect and gap junctional communication in lung cancer cell lines.
Imaizumi K; Hasegawa Y; Kawabe T; Emi N; Saito H; Naruse K; Shimokata K
Am J Respir Cell Mol Biol; 1998 Feb; 18(2):205-12. PubMed ID: 9476907
[TBL] [Abstract][Full Text] [Related]
32. Cytogenetic detection of a trans-species bystander effect: induction of sister chromatid exchanges in murine 3T3 cells by ganciclovir metabolized in HSV thymidine kinase gene-transfected Chinese hamster ovary cells.
Thust R; Tomicic MT; Gräbner R; Friedrichs C; Wutzler P; Kaina B
Mutagenesis; 2004 Jan; 19(1):27-33. PubMed ID: 14681310
[TBL] [Abstract][Full Text] [Related]
33. Massive apoptotic cell death in chemically induced rat urinary bladder carcinomas following in situ HSVtk electrogene transfer.
Shibata MA; Horiguchi T; Morimoto J; Otsuki Y
J Gene Med; 2003 Mar; 5(3):219-31. PubMed ID: 12666188
[TBL] [Abstract][Full Text] [Related]
34. Retrovirus-mediated herpes simplex virus thymidine kinase gene transduction renders human thyroid carcinoma cell lines sensitive to ganciclovir and radiation in vitro and in vivo.
Nishihara E; Nagayama Y; Mawatari F; Tanaka K; Namba H; Niwa M; Yamashita S
Endocrinology; 1997 Nov; 138(11):4577-83. PubMed ID: 9348181
[TBL] [Abstract][Full Text] [Related]
35. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir.
Namba H; Tagawa M; Miyagawa T; Iwadate Y; Sakiyama S
Cancer Gene Ther; 2000 Jun; 7(6):947-53. PubMed ID: 10880027
[TBL] [Abstract][Full Text] [Related]
36. Suppression of murine mammary carcinoma growth and metastasis by HSVtk/GCV gene therapy using in vivo electroporation.
Shibata MA; Morimoto J; Otsuki Y
Cancer Gene Ther; 2002 Jan; 9(1):16-27. PubMed ID: 11916241
[TBL] [Abstract][Full Text] [Related]
37. Connexin over-expression differentially suppresses glioma growth and contributes to the bystander effect following HSV-thymidine kinase gene therapy.
Jimenez T; Fox WP; Naus CC; Galipeau J; Belliveau DJ
Cell Commun Adhes; 2006; 13(1-2):79-92. PubMed ID: 16613782
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
Yang L; Hwang R; Chiang Y; Gordon EM; Anderson WF; Parekh D
Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543
[TBL] [Abstract][Full Text] [Related]
39. HSVtk/GCV system on hepatoma carcinoma cells: Construction of the plasmid pcDNA3.1‑pAFP-TK and targeted killing effect.
Li YF; Yuan YY; Zhang YM; Zhao N; Zhang Q; Meng FX; Gao RP; Yu BF; Zhang YH; Guo R; Wang HL; Xie J; Xu J; Qin Q; Dong XS
Mol Med Rep; 2017 Jul; 16(1):764-772. PubMed ID: 28560395
[TBL] [Abstract][Full Text] [Related]
40. Suicide gene therapy using AAV-HSVtk/ganciclovir in combination with irradiation results in regression of human head and neck cancer xenografts in nude mice.
Kanazawa T; Mizukami H; Okada T; Hanazono Y; Kume A; Nishino H; Takeuchi K; Kitamura K; Ichimura K; Ozawa K
Gene Ther; 2003 Jan; 10(1):51-8. PubMed ID: 12525837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
